Carboxylesterase 1D
| GO Term | Evidence Code | Reference |
|---|---|---|
| acyl-CoA metabolic process | ||
| response to toxic substance | ||
| lipid catabolic process | ||
| lipid catabolic process | ||
| short-chain fatty acid catabolic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytoplasm | ||
| endoplasmic reticulum | ||
| endoplasmic reticulum | ||
| endoplasmic reticulum | ||
| endoplasmic reticulum |
| GO Term | Evidence Code | Reference |
|---|---|---|
| sterol ester esterase activity | ||
| sterol ester esterase activity | ||
| triacylglycerol lipase activity | ||
| fatty-acyl-ethyl-ester synthase activity | ||
| fatty-acyl-ethyl-ester synthase activity |
| Pathway Name | Organism |
|---|---|
| Aspirin ADME | Mus musculus |
| Metabolism of Angiotensinogen to Angiotensins | Mus musculus |
| Phase I - Functionalization of compounds | Mus musculus |
| Physiological factors | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026